{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:02:40Z","timestamp":1788134560456,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","heartrhythmjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.hrthm.2015.01.021","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T11:02:57Z","timestamp":1421492577000},"page":"872-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study"],"prefix":"10.1016","volume":"12","author":[{"given":"Gaetano M.","family":"De Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars S.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Mont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0367-1048","authenticated-orcid":false,"given":"Peter J.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Simonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Leschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Gronda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Darius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Guillam\u00f3n Tor\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Savelieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Dusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Quintana Rend\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Tonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Melani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alberto Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"John Camm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2015.01.021_bib1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2015.01.021_bib2","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jacc.2010.09.013","volume":"57","author":"Fuster","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib3","first-page":"205","article-title":"FIRE Investigators. Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission","volume":"5","author":"Santini","year":"2004","journal-title":"Data from the atrial Fibrillation\/flutter Italian REgistry (FIRE). Ital Heart J"},{"key":"10.1016\/j.hrthm.2015.01.021_bib4","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"European Heart Survey Investigators. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2015.01.021_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.03.034","article-title":"Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation)","volume":"58","author":"Camm","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2012.12.019","article-title":"Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry","volume":"165","author":"Steinberg","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2015.01.021_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0735-1097(97)00220-9","article-title":"Adverse effects of low dose amiodarone: a meta-analysis","volume":"30","author":"Vorperian","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11886-006-0077-z","article-title":"Atrial fibrillation: choosing an antiarrhythmic drug","volume":"8","author":"Rudo","year":"2006","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hrthm.2015.01.021_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","article-title":"A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study","volume":"21","author":"Le Heuzey","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1517\/14740338.2012.722994","article-title":"Drug safety evaluation of dronedarone in atrial fibrillation","volume":"11","author":"De Ferrari","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.hrthm.2015.01.021_bib11","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/CIRCULATIONAHA.105.597500","article-title":"Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions","volume":"113","author":"Chaitman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.01.021_bib12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jacc.2006.10.067","article-title":"Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE)","volume":"49","author":"Koren","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib13","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"MERLIN-TIMI 36 Trial Investigators. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2015.01.021_bib14","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.107.724880","volume":"116","author":"Scirica","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2015.01.021_bib15","first-page":"260","article-title":"The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible \u201cpill in the pocket\u201d approach to atrial fibrillation","volume":"9","author":"Murdock","year":"2009","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.hrthm.2015.01.021_bib16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1540-8159.2011.03298.x","article-title":"The use of ranolazine to facilitate electrical cardioversion in cardioversion-resistant patients: a case series","volume":"35","author":"Murdock","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib17","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jacc.2009.12.055","article-title":"Altered Na+ currents in atrial fibrillation: Effects of ranolazine on arrhythmias and contractility in human atrial myocardium","volume":"55","author":"Sossalla","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.hrthm.2011.03.045","article-title":"Electrophysiologic basis for the antiarrhythmic actions of ranolazine","volume":"8","author":"Antzelevitch","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.01.021_bib19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0195-668X(03)00321-X","article-title":"Dronedarone for prevention of atrial fibrillation: a dose-ranging study","volume":"24","author":"Touboul","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2015.01.021_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0735-1097(97)00455-5","article-title":"Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?","volume":"31","author":"Tieleman","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib21","doi-asserted-by":"crossref","first-page":"e004418","DOI":"10.1136\/bmjopen-2013-004418","article-title":"Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis","volume":"4","author":"Yo","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.hrthm.2015.01.021_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.hrthm.2008.03.018","article-title":"Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations","volume":"5","author":"Sicouri","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2015.01.021_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1196\/annals.1420.012","article-title":"Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation","volume":"1123","author":"Burashnikov","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.hrthm.2015.01.021_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/europace\/eus380","article-title":"Mechanisms of ranolazine\u2019s dual protection against atrial and ventricular fibrillation","volume":"15","author":"Verrier","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2015.01.021_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCEP.111.962340","article-title":"A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion","volume":"4","author":"Torp-Pedersen","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib26","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jacc.2010.08.600","article-title":"Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation","volume":"56","author":"Burashnikov","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCEP.109.886275","article-title":"Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria","volume":"3","author":"Sicouri","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2015.01.021_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.hrthm.2012.09.015","article-title":"Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia","volume":"10","author":"Verrier","year":"2013","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.hrthm.2015.01.021_bib29","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1111\/1755-5922.12035","article-title":"Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation","volume":"31","author":"Frommeyer","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.hrthm.2015.01.021_bib30","unstructured":"Press Release. Gilead announces results from phase 2 study showing reduction in atrial fibrillation burden with the investigational combination of ranolazine and low-dose dronedarone. Available at: http:\/\/online.wsj.com\/article\/PR-CO-20140510-902413.html. Accessed May 26, 2014."},{"key":"10.1016\/j.hrthm.2015.01.021_bib31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/europace\/eut407","article-title":"Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation","volume":"16","author":"Koskinas","year":"2014","journal-title":"Europace"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527115000715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527115000715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T03:26:02Z","timestamp":1537932362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527115000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1547527115000715"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2015.01.021","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2015.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}